BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18006474)

  • 41. Phospholemman-mediated activation of Na/K-ATPase limits [Na]i and inotropic state during beta-adrenergic stimulation in mouse ventricular myocytes.
    Despa S; Tucker AL; Bers DM
    Circulation; 2008 Apr; 117(14):1849-55. PubMed ID: 18362230
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic SR Ca2+-ATPase inhibition causes adaptive changes in cellular Ca2+ transport.
    Brittsan AG; Ginsburg KS; Chu G; Yatani A; Wolska BM; Schmidt AG; Asahi M; MacLennan DH; Bers DM; Kranias EG
    Circ Res; 2003 Apr; 92(7):769-76. PubMed ID: 12637367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protein kinase A hyperphosphorylation increases basal current but decreases beta-adrenergic responsiveness of the sarcolemmal Na+-Ca2+ exchanger in failing pig myocytes.
    Wei SK; Ruknudin A; Hanlon SU; McCurley JM; Schulze DH; Haigney MC
    Circ Res; 2003 May; 92(8):897-903. PubMed ID: 12676818
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phosphorylation of the ryanodine receptor 2 at serine 2030 is required for a complete β-adrenergic response.
    Potenza DM; Janicek R; Fernandez-Tenorio M; Camors E; Ramos-Mondragón R; Valdivia HH; Niggli E
    J Gen Physiol; 2019 Feb; 151(2):131-145. PubMed ID: 30541771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of dual-site phospholamban phosphorylation in the stunned heart: insights from phospholamban site-specific mutants.
    Said M; Vittone L; Mundina-Weilenmann C; Ferrero P; Kranias EG; Mattiazzi A
    Am J Physiol Heart Circ Physiol; 2003 Sep; 285(3):H1198-205. PubMed ID: 12763747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuregulins regulate cardiac parasympathetic activity: muscarinic modulation of beta-adrenergic activity in myocytes from mice with neuregulin-1 gene deletion.
    Okoshi K; Nakayama M; Yan X; Okoshi MP; Schuldt AJ; Marchionni MA; Lorell BH
    Circulation; 2004 Aug; 110(6):713-7. PubMed ID: 15289373
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impaired Ca2+ handling and contraction in cardiomyocytes from mice with a dominant negative thyroid hormone receptor alpha1.
    Tavi P; Sjögren M; Lunde PK; Zhang SJ; Abbate F; Vennström B; Westerblad H
    J Mol Cell Cardiol; 2005 Apr; 38(4):655-63. PubMed ID: 15808842
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I.
    Frantz S; Klaiber M; Baba HA; Oberwinkler H; Völker K; Gaβner B; Bayer B; Abeβer M; Schuh K; Feil R; Hofmann F; Kuhn M
    Eur Heart J; 2013 Apr; 34(16):1233-44. PubMed ID: 22199120
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phosphorylation of phospholamban at threonine-17 in the absence and presence of beta-adrenergic stimulation in neonatal rat cardiomyocytes.
    Bartel S; Vetter D; Schlegel WP; Wallukat G; Krause EG; Karczewski P
    J Mol Cell Cardiol; 2000 Dec; 32(12):2173-85. PubMed ID: 11112993
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HuR regulates phospholamban expression in isoproterenol-induced cardiac remodelling.
    Hu H; Jiang M; Cao Y; Zhang Z; Jiang B; Tian F; Feng J; Dou Y; Gorospe M; Zheng M; Zheng L; Yang Z; Wang W
    Cardiovasc Res; 2020 Apr; 116(5):944-955. PubMed ID: 31373621
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional interplay between dual site phospholambam phosphorylation: insights from genetically altered mouse models.
    Chu G; Kranias EG
    Basic Res Cardiol; 2002; 97 Suppl 1():I43-8. PubMed ID: 12479233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of protein phosphatase 1 by inhibitor-2 exacerbates progression of cardiac failure in a model with pressure overload.
    Grote-Wessels S; Baba HA; Boknik P; El-Armouche A; Fabritz L; Gillmann HJ; Kucerova D; Matus M; Müller FU; Neumann J; Schmitz M; Stümpel F; Theilmeier G; Wohlschlaeger J; Schmitz W; Kirchhefer U
    Cardiovasc Res; 2008 Aug; 79(3):464-71. PubMed ID: 18453636
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute inotropic and lusitropic effects of cardiomyopathic R9C mutation of phospholamban.
    Abrol N; de Tombe PP; Robia SL
    J Biol Chem; 2015 Mar; 290(11):7130-40. PubMed ID: 25593317
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A human polymorphism of protein phosphatase-1 inhibitor-1 is associated with attenuated contractile response of cardiomyocytes to beta-adrenergic stimulation.
    Chen G; Zhou X; Nicolaou P; Rodriguez P; Song G; Mitton B; Pathak A; Zachariah A; Fan GC; Dorn GW; Kranias EG
    FASEB J; 2008 Jun; 22(6):1790-6. PubMed ID: 18192322
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase.
    Curran J; Hinton MJ; Ríos E; Bers DM; Shannon TR
    Circ Res; 2007 Feb; 100(3):391-8. PubMed ID: 17234966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor necrosis factor-alpha decreases the phosphorylation levels of phospholamban and troponin I in spontaneously beating rat neonatal cardiac myocytes.
    Yokoyama T; Arai M; Sekiguchi K; Tanaka T; Kanda T; Suzuki T; Nagai R
    J Mol Cell Cardiol; 1999 Jan; 31(1):261-73. PubMed ID: 10072733
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oligomeric interactions between phospholamban molecules regulate Ca-ATPase activity in functionally reconstituted membranes.
    Yao Q; Chen LT; Li J; Brungardt K; Squier TC; Bigelow DJ
    Biochemistry; 2001 May; 40(21):6406-13. PubMed ID: 11371203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phospholamban phosphorylation in ischemia-reperfused heart. Effect of pacing during ischemia and response to a beta-adrenergic challenge.
    Mundiña-Weilenmann C; Said M; Vittone L; Ferrero P; Mattiazzi A
    Mol Cell Biochem; 2003 Oct; 252(1-2):239-46. PubMed ID: 14577598
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
    Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
    Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phospholemman is a negative feed-forward regulator of Ca2+ in β-adrenergic signaling, accelerating β-adrenergic inotropy.
    Yang JH; Saucerman JJ
    J Mol Cell Cardiol; 2012 May; 52(5):1048-55. PubMed ID: 22289214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.